Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
BMJ Open Diabetes Research & Care|October 10, 2020
Further improvement in glycemic control after switching from exenatide two times per day to exenatide once-weekly autoinjected suspension in patients with type 2 diabetes: 52-week results from the DURATION-NEO-1 studyCarol H Wysham, Julio Rosenstock, Marion L Vetter, et al.Diabetes, Obesity & Metabolism|July 8, 2017
Efficacy and tolerability of the new autoinjected suspension of exenatide once weekly versus exenatide twice daily in patients with type 2 diabetesCarol H Wysham, Julio Rosenstock, Marion L Vetter, et al.Journal of the American College of Nutrition|August 12, 2008
What do resident physicians know about nutrition? An evaluation of attitudes, self-perceived proficiency and knowledgeMarion L Vetter, Sharon J Herring, Minisha Sood, et al.Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|March 26, 2011
Effect of a low-carbohydrate diet versus a low-fat, calorie-restricted diet on adipokine levels in obese, diabetic participantsMarion L Vetter, Alisha Wade, Leslie G Womble, et al.Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|March 6, 2012
Physicians' attitudes about referring their type 2 diabetes patients for bariatric surgeryDavid B Sarwer, Scott Ritter, Thomas A Wadden, et al.Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|December 25, 2012
Attitudes about the safety and efficacy of bariatric surgery among patients with type 2 diabetes and a body mass index of 30-40 kg/m2David B Sarwer, Scott Ritter, Thomas A Wadden, et al.Pharmacology Research & Perspectives|March 30, 2016
Bioequivalence of saxagliptin/dapagliflozin fixed-dose combination tablets compared with coadministration of the individual tablets to healthy subjectsBlisse Vakkalagadda, Marion L Vetter, Jignasa Rana, et al.Journal of Clinical Pharmacology|May 17, 2017
A Systematic Review and Pooled Analysis of Select Safety Parameters Among Normal Healthy Volunteers Taking Placebo in Phase 1 Clinical TrialsTina C Young, Subasree Srinivasan, Marion L Vetter, et al.Obesity (Silver Spring, Md.)|July 16, 2011
Patients' preferred terms for describing their excess weight: discussing obesity in clinical practiceSheri Volger, Marion L Vetter, Megan Dougherty, et al.Obesity (Silver Spring, Md.)|December 19, 2009
Effects of a low-intensity intervention that prescribed a low-carbohydrate vs. a low-fat diet in obese, diabetic participantsNayyar Iqbal, Marion L Vetter, Reneé H Moore, et al.Pageof 3